Tolerability and effectiveness of glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease
But for many people, it can be an effective tool for reducing overall caloric intake, improving hunger regulation, and supporting long-term consistency, especially when paired with medications that support appetite control, like semaglutide or similar GLP-1s
PMCID: PMC5112015
This likely reflects the glucagon receptor activation increasing sympathetic tone and thermogenesis, the same mechanism that drives the additional metabolic benefits
Clinical trials showed Mounjaro produces greater weight loss (22.5% versus 14.9% average)
Risks in the Cold Chain Shipping and storing GLP-1 drugs comes with challenges: Transport delays or exposure during loading and unloading Human error such as leaving shipments unrefrigerated Dead space in packaging that creates uneven cooling Inadequate monitoring that leaves excursions unnoticed Each of these risks can disrupt the cold chain, which is why reliable GLP-1 monitoring systems are essential to detect and prevent excursions